Regulatory authorities review use of galantamine in mild cognitive impairment
AUTOR(ES)
Mayor, Susan
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=548208Documentos Relacionados
- Subjective memory and strategy use in mild cognitive impairment and healthy aging
- Subclinical cerebrovascular disease in mild cognitive impairment
- Semantic memory activation in amnestic mild cognitive impairment
- Dementia and mild cognitive impairment in Parkinson's disease
- Dementia and mild cognitive impairment in Parkinson's disease